Founded in 1997, Advanced Circulatory has developed a novel platform therapy called Perfusion on Demand™ -- a therapy that has life-saving implications for multiple emergency medical conditions. Perfusion on Demand is a non-invasive therapy that increases circulation, protecting the heart, brain and other vital organs when blood flow is compromised. This gives rescuers and caregivers the potential to return patients to a full life after severe medical emergencies. The company manufactures and markets the ResQPOD® (Perfusion on Demand) and the ResQGARD® impedance threshold devices.
The ResQPOD Impedance Threshold Device (ITD) prevents air from entering the lungs during chest wall recoil. This enhances the vacuum (negative pressure) in the chest, which pulls more blood back into the heart and lowers intracranial pressure. As a result, more blood is circulated to vital organs until the heart can be restarted.
The ResQGARD is an Impedance Threshold Device (ITD) that provides a safe, simple and convenient way to treat states of low blood pressure in spontaneously breathing patients. The ResQGARD provides therapeutic benefit as soon as a patient begins to breathe through it. Studies have shown that the ResQGARD increases blood pressure during hypotension from a variety of causes.